Clinical Trial Update: K-Basket, Avelumab, Biomarker-driven, Advanced Solid Tumor [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update for avelumab in biomarker-driven advanced solid tumors, including PD-L1 positive, EBV-positive, MSI-H, and POLE/POLD1 mutation t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ebv Positive Mutation Tumor
• Msi-h Mutation Tumor
• Pd-l1 Positive Mutation Tumor
• Pole Pold1 Mutation Tumor
• Solid Tumors

Drugs mentioned

• Avelumab (avelumab)

Snippet

Sponsor: Yonsei University | Conditions: PD-L1 Positive Mutation Tumor, EBV Positive Mutation Tumor | Phase 2 | Status: UNKNOWN